(Press-News.org) PHILADELPHIA (October 12, 2010)—In an unexpected twist, Fox Chase Cancer Center researchers find that the loss of a single protein, Nedd9, initially slows cancer formation but then makes the tumors that do arise more aggressive. The good news, though, is that the lack of Nedd9 also makes the aggressive tumors more sensitive to a class of drugs that are already used in the clinic.
"If a tumor is able to overcome the loss of this protein, this clearly makes it undergo complicated changes that ultimately select for a more aggressive tumor," says Erica A. Golemis, Ph.D., professor and co-leader of developmental therapeutics at Fox Chase, and senior author on the new study, published online October 12 in Cancer Research. "It is reminiscent of the situation you get when you treat cancer patients with a drug and get an initial response. However, eventually their tumor overrides the drug, and then you have a really tough tumor."
A number of studies have shown that increased Nedd9 expression is associated with metastasis in a variety of human cancers, including breast cancer. Last year, Golemis's group reported that deleting Nedd9 from a mouse model of breast cancer delayed tumor growth, compared with control animals. Now, they report that the cells isolated from the Nedd9-deficient tumors more rapidly form new tumors in mice, and more readily give rise to lung metastases, in contrast to tumors with normal levels of Nedd9.
Because Nedd9 interacts directly with Src, a protein that has been a major drug development target, lead author on the study, Mahendra K. Singh, Ph.D., tested whether the Src inhibitor dasatinib, already approved for cancer treatment, would control the aggressive Nedd9-deficient tumors. He found that dasatinib rapidly killed the Nedd9-deficient tumor cells, even at low doses.
Golemis, Singh, and colleagues now hope to partner with clinician colleagues in trials to compare action of the drug in breast cancer patients whose tumors have low Nedd9 expression. "My hunch is that this is going to be very important for understanding how best to treat patients in the future," Singh said.
###
Fox Chase Cancer Center is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation's first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center's nursing program has received the Magnet status for excellence three consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, visit Fox Chase's Web site at www.fccc.org or call 1-888-FOX CHASE or (1-888-369-2427).
END
Researchers at the University of Edinburgh today report a new experimental compound that can improve memory and cognitive function in ageing mice. The compound is being investigated with a view to developing a drug that could slow the natural decline in memory associated with ageing.
With support from a Wellcome Trust Seeding Drug Discovery award, the team has identified a preclinical candidate that they hope to take into human trials within a year.
Many people find they become more forgetful as they get older and we generally accept it as a natural part of the ageing ...
The drug reboxetine is, overall, an ineffective and potentially harmful antidepressant, according to a comprehensive study of the evidence published on bmj.com today.
The study also shows that nearly three quarters of the data on patients who took part in trials of reboxetine were not published until now, and that the published data on the drug overestimate the benefits and underestimate the harms of treatment - all underlining the urgent need for mandatory publication of all clinical trial results.
Reboxetine has been approved for the treatment of major depressive ...
To assess the performance of general practices, it is better to ask patients about their actual experiences of care rather than ask for satisfaction ratings, according to new research published on bmj.com today.
The findings call into question the reliability of using surveys to evaluate practice performance.
Patient surveys are used to assess the performance of doctors and practices, and they increasingly enquire about specific patient experiences (e.g. waiting time for an appointment) as well as overall satisfaction.
In the UK, general practices receive some of ...
In a Canadian first, the Peter Munk Cardiac Centre used a new kind of left ventricular assist device (LVAD) to treat a patient with advanced heart failure. The new device is longer lasting than older generation LVADs and may eliminate the need for a second LVAD – a major drawback with the old technology.
The patient, 61-year-old Marva Lorde of Mississauga, suffered a heart attack in 2007 and underwent several treatments for heart failure – including a 10-day intensive care unit stay, angioplasty and pacemaker implantation –culminating in a cardiac arrest in June 2008.
"I ...
With Halloween and the holiday season fast approaching, many people will be watching their waistlines as they're tempted by a cornucopia of sugary and savory foods. Meanwhile a Georgia Tech College of Computing Ph.D. candidate has shown that playing health-related video games on a mobile device can help adults learn to live more healthfully by making smart diet choices. The finding is published in the paper, "Let's Play! Mobile Health Games for Adults," recently presented at Ubicomp 2010 in Copenhagen, Denmark.
OrderUP! is a different take on the recent trend of health-related ...
An innovative experiment at the University of Leicester that involved studying rotting fish has helped to create a clearer picture of what our early ancestors would have looked like.
The scientists wanted to examine the decaying process in order to understand the decomposition of soft-body parts in fish. This in turn will help them reconstruct an image of creatures that existed 500 million years ago.
Their findings have been published today, Wednesday 13th October, in the journal Proceedings of the Royal Society B. The work was funded by the Natural Environment Research ...
Eating steamed pears, having a soothing massage or bathing in a herbal mixture are just some of indigenous health practices used by older people to ward off or treat influenza, according to research published in the October issue of the Journal of Advanced Nursing.
Other traditional measures discovered by nurse researchers at the Hong Kong Polytechnic University included being rubbed with a coin, eating cheese, yoghurt and honey and having warm drinks made with ginger or lemon.
The team surveyed nine countries to find out why so many of them were failing to meet the ...
Winter canola might soon be the crop of choice for Pacific Northwest farmers, thanks to research by U.S. Department of Agriculture (USDA) scientists and their partners. The multitasking annual plant can be used to control weeds, supplement animal feed, produce biodiesel--and spark a new revenue stream for the Colville Confederated Tribes.
Frank Young, an agronomist with USDA's Agricultural Research Service (ARS), was part of a team that evaluated production protocols for winter canola in the Pacific Northwest. ARS is USDA's principal intramural scientific research agency. ...
Scientists at the University of Leicester are using an unusual resource to investigate ancient climates– prehistoric animal urine.
The animal in question is the rock hyrax, a common species in countries such as Namibia and Botswana. They look like large guinea pigs but are actually related to the elephant. Hyraxes use specific locations as communal toilets, some of which have been used by generations of animals for thousands of years. The urine crystallises and builds up in stratified accumulations known as 'middens', providing a previously untapped resource for studying ...
Scientists at the UK's National Physical Laboratory (NPL) have developed a means of representing a 3D model ear, to help redefine the standard for a pinna simulator (the pinna is the outer part of the ear) – used to measure sound in the way we perceive it.
The nature of human hearing is heavily dependent on the shape of the head and torso, and their interaction with sound reaching the ears allows for the perception of location within a 3D sound field.
Head and Torso Simulators (HATS) are designed to model this behaviour, enabling measurements and recordings to be made ...
